Regeneron Announces Investor Conference Presentations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
BMO Capital Assumes Regeneron Pharma (REGN) at Outperform
November 18, 2021 4:17 PM ESTBMO Capital analyst Evan David Seigerman assumes coverage on Regeneron Pharma (NASDAQ: REGN) with a Outperform rating and a price target of $780.00.
The analyst comments "We are assuming coverage of Regeneron from Matt Luchini and maintaining our Outperform rating with a $780... More
